Erin Schuler, PhD

Director, Chemistry, Special Chemistry, and Point of Care, Division of Pathology and Laboratory Medicine
Assistant Professor, UC Department of Pathology and Laboratory Medicine

About

Bachelor of Science: Dual Major, Chemistry and Biology, Youngstown State University Youngstown, OH, Aug. 2004–Aug. 2008.

Doctor of Philosophy: Chemistry, Emory University, Laney Graduate School of Arts and Sciences, Atlanta, GA, Aug. 2008–Aug. 2015.

Postdoctoral Research: Emory University Atlanta, GA, July 2015-–Jan. 2018.

Clinical Chemistry Fellow: University of Kentucky, Department of Pathology and Laboratory Medicine, Lexington, KY, Jan. 2018–Jan. 2020.

Pathology

Cystatin C Outperforms Creatinine in Predicting Cefepime Clearance in Pediatric Stem Cell Transplant Recipients. Hambrick, HR; Fei, L; Pavia, K; Kaplan, J; Mizuno, T; Tang, P; Schuler, E; Benoit, S; Girdwood, ST. Transplantation and Cellular Therapy. 2024; 30:614.e1-614.e11.

Artesunate acts through cytochrome c to inhibit growth of pediatric AML cells. Hill, KS; Schuler, EE; Ellingson, SR; Kolesar, JM. Scientific Reports. 2023; 13:22383.

AACC Guidance Document on Laboratory Testing for the Assessment of Preterm Delivery. Farnsworth, C; Schuler, EE; Woodworth, A; Straseski, J; Pschirrer, ER; Nerenz, RD. The journal of applied laboratory medicine. 2021; 6:1032-1044.

KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer. Hill, KS; McDowell, A; McCorkle, JR; Schuler, E; Ellingson, SR; Plattner, R; Kolesar, JM. Cancers. 2021; 13:1885.

Potential Process Control Issues with Remdesivir. Almeter, PJ; Isaacs, JT; Schuler, EE; Lodder, RA. 2021; 2021.